Therefore, CD277-specific antibodies can restore the effector activity of αβT cells and induce BTN3A activity to mediate the synergistic killing of BTN3A1+ tumor cells by αβT cells and γδT cells in a BTN2A1-dependent manner. This evidence concerns the gene BTN3A2 and neoplasm.